PROCEPT BioRobotics (NASDAQ:PRCT) Given New $95.00 Price Target at Truist Financial

PROCEPT BioRobotics (NASDAQ:PRCT – Free Report) had its target price hoisted by Truist Financial from $74.00 to $95.00 in a research note released on Tuesday morning, Benzinga reports. Truist Financial currently has a buy rating on the stock. A number of other analysts also recently weighed in on the company. Wells Fargo & Company boosted […]